NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

A Study to Learn How Different Forms of the Study Medicine Called PF-07976016 Are Taken Up Into the Blood in Healthy Adults

NCT06670170

CompletedPhase 1

Sponsor: Pfizer

Conditions: Healthy Volunteers

Interventions: PF-07976016 Formulation A, PF-07976016 Formulation B

Countries: United States

The primary purpose of this study is to measure and compare the amount of study drug in your blood after a single dose of two formulations of study drug.

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: Yes

Study type: INTERVENTIONAL

Eligibility criteria

Key Inclusion Criteria:

* Overtly healthy as determined by medical evaluation including medical history, physical examination, laboratory tests, vital signs and ECG assessments.
* Willing to provide consent and follow study requirements
* Total body weight \>110lbs (50kg)

Key Exclusion Criteria:

* Any condition affecting drug absorption, clinically significant laboratory values
* HIV, HepB \& HepC
* Serious illness or hospitalization, or other condition, that may increase the risk of study participation or, in the investigator's judgment, make the participant inappropriate for the study.
* Use of prescription or non-prescription drugs within a specified timeframe prior to the first dose of study intervention
* positive urine drug test at screening/admission
* History of alcohol abuse or repeated binge drinking and/or any other illicit drug use or dependence within 6 months of screening
* Use of tobacco/nicotine containing products more than the equivalent of 5 cigarettes/day or 2 chews of tobacco/day

Locations (1)

New Haven, Connecticut, United States